摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(4-methoxyphenyl)ethyl]-4-methylaniline

中文名称
——
中文别名
——
英文名称
N-[2-(4-methoxyphenyl)ethyl]-4-methylaniline
英文别名
[2-(4-Methoxy-phenyl)-ethyl]-p-tolyl-amine
N-[2-(4-methoxyphenyl)ethyl]-4-methylaniline化学式
CAS
——
化学式
C16H19NO
mdl
MFCD02603500
分子量
241.333
InChiKey
ZRRBAZPTYVNIAS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    参考文献:
    名称:
    甲醇中2-苯乙基苯磺酸酯与苯胺反应的动力学和机理
    摘要:
    研究了在65.0°C下2-苯乙基苯磺酸盐与苯胺在甲醇中的反应动力学。该机构被交叉相互作用常数,ρ的基础上讨论IJ。发现整个反应是通过离解的S N 2机理进行的,其中芳基的参与程度相对较小。亲核辅助途径中,亲核试剂苯胺所捕获的苯离子中间体的分数已显示出随着亲核试剂的增强而增加,并且对于芳基-建议在分子间S N i机理中出现四中心过渡态。无辅助路径。
    DOI:
    10.1039/p29880001537
点击查看最新优质反应信息

文献信息

  • An (Aminopyrimidinato)titanium Catalyst for the Hydroamination of Alkynes and Alkenes
    作者:Christian Brahms、Patrik Tholen、Wolfgang Saak、Sven Doye
    DOI:10.1002/ejoc.201301004
    日期:2013.11
    (aminopyrimidinato)titanium complex has been synthesised from inexpensive and easily accessible 2-(tert-butylamino)pyrimidine and [Ti(NMe2)4] and used as a catalyst for the intermolecular hydroamination of alkynes as well as the cyclization of aminoalkenes. The hydroamination reactions of 1-phenylpropyne and terminal arylalkynes deliver the corresponding anti-Markovnikov addition products with excellent yields and
    一种新的(氨基嘧啶合)钛络合物已由廉价且易于获得的 2-(叔丁基氨基)嘧啶和 [Ti(NMe2)4] 合成,并用作炔烃分子间加氢胺化以及氨基烯烃环化的催化剂。1-苯基丙炔和末端芳基炔烃的加氢胺化反应以优异的产率和区域选择性提供相应的反马尔科夫尼科夫加成产物。
  • Titanium and Zirconium Complexes with Helical Bis(phenolato) Ligands as Hydroamination Catalysts
    作者:Sven Doye、Klaudia Marcseková、Christian Loos、Frank Rominger
    DOI:10.1055/s-2007-986651
    日期:2007.10
    2-cyclohexanediyl backbone can be obtained in two steps from commercially available starting materials. In situ combination of this ligand with Ti(NMe 2 ) 4 or Zr(NMe 2 ) 4 results in the formation of bis(phenolato) complexes that catalyze hydroaminations ofalkynes and alkenes.
    包含反式-1,2-环己二基主链的外消旋双酚 (OSSO) 型配体可以从市售的起始材料中分两步获得。该配体与Ti(NMe 2 ) 4 或Zr(NMe 2 ) 4 的原位组合导致催化炔烃和烯烃的加氢胺化的双(苯酚)络合物的形成。
  • GLYCOPEPTIDE COMPOUNDS HAVING ACTIVITY OF RESISTING DRUG-RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    申请人:Shanghai LaiYi Center For Biopharmaceutical R&D Co., Ltd.
    公开号:EP3763728A1
    公开(公告)日:2021-01-13
    The present invention discloses glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I), The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema,
    本发明公开了具有抗耐药性细菌活性的糖肽化合物,符合通式(I)所代表的糖肽化合物、 本发明还提供了糖肽化合物的制备方法和应用。经测试,与第二代糖肽药物奥利他万星(oritavancin)相比,糖肽抗生素化合物对耐药菌株,尤其是 MRSA 或 VRE 具有更高的抑制活性。进一步的测试表明,大多数糖肽化合物的安全性高于奥利他万星,可以制备成药物,用于治疗或预防各种细菌感染引起的疾病,如皮肤和软组织感染、脑膜炎、败血症、肺炎、关节炎、腹膜炎、支气管炎和肺水肿、
  • Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof
    申请人:Shanghai LaiYi Center For Biopharmaceutical R&D Co
    公开号:US20210093691A1
    公开(公告)日:2021-04-01
    The present invention discloses glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I), The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.
  • Kinetics and mechanism of reactions between 2-phenylethyl benzenesulphonates and anilines in methanol
    作者:Ikchoon Lee、Yong Hoon Choi、Hai Whang Lee、Byung Choon Lee
    DOI:10.1039/p29880001537
    日期:——
    Kinetics of reactions between 2-phenylethyl benzenesulphonates and anilines in methanol at 65.0 °C have been studied; the mechanism is discussed on the basis of cross interaction constants, ρij. The overall reaction was found to proceed by a dissociative SN2 mechanism with a relatively small degree of aryl participation. The fraction of the phenonium ion intermediate captured by the nucleophile, aniline
    研究了在65.0°C下2-苯乙基苯磺酸盐与苯胺在甲醇中的反应动力学。该机构被交叉相互作用常数,ρ的基础上讨论IJ。发现整个反应是通过离解的S N 2机理进行的,其中芳基的参与程度相对较小。亲核辅助途径中,亲核试剂苯胺所捕获的苯离子中间体的分数已显示出随着亲核试剂的增强而增加,并且对于芳基-建议在分子间S N i机理中出现四中心过渡态。无辅助路径。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐